These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
474 related articles for article (PubMed ID: 24245956)
21. TACI and BAFF-R mediate isotype switching in B cells. Castigli E; Wilson SA; Scott S; Dedeoglu F; Xu S; Lam KP; Bram RJ; Jabara H; Geha RS J Exp Med; 2005 Jan; 201(1):35-9. PubMed ID: 15630136 [TBL] [Abstract][Full Text] [Related]
22. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. Avery DT; Kalled SL; Ellyard JI; Ambrose C; Bixler SA; Thien M; Brink R; Mackay F; Hodgkin PD; Tangye SG J Clin Invest; 2003 Jul; 112(2):286-97. PubMed ID: 12865416 [TBL] [Abstract][Full Text] [Related]
23. Increased BCMA expression in lupus marks activated B cells, and BCMA receptor engagement enhances the response to TLR9 stimulation. Kim J; Gross JA; Dillon SR; Min JK; Elkon KB Autoimmunity; 2011 Mar; 44(2):69-81. PubMed ID: 21250838 [TBL] [Abstract][Full Text] [Related]
24. Signaling pathways for B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) in human placenta. Langat DL; Wheaton DA; Platt JS; Sifers T; Hunt JS Am J Pathol; 2008 May; 172(5):1303-11. PubMed ID: 18403603 [TBL] [Abstract][Full Text] [Related]
25. Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus. Salazar-Camarena DC; Ortiz-Lazareno PC; Cruz A; Oregon-Romero E; Machado-Contreras JR; Muñoz-Valle JF; Orozco-López M; Marín-Rosales M; Palafox-Sánchez CA Lupus; 2016 May; 25(6):582-92. PubMed ID: 26424128 [TBL] [Abstract][Full Text] [Related]
27. Novel function of TNF cytokines in regulating bone marrow B cell survival. Zhang M; Ko KH; Lam QL; Lo CK; Xu DJ; Shen L; Zheng B; Srivastava G; Lu L Cell Mol Immunol; 2004 Dec; 1(6):447-53. PubMed ID: 16293214 [TBL] [Abstract][Full Text] [Related]
28. Expression of TNF-α, APRIL and BCMA in Behcet's disease. Shaker OG; Tawfic SO; El-Tawdy AM; El-Komy MH; El Menyawi M; Heikal AA J Immunol Res; 2014; 2014():380405. PubMed ID: 25759827 [TBL] [Abstract][Full Text] [Related]
29. Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation. Ghia P; Chiorazzi N; Stamatopoulos K J Intern Med; 2008 Dec; 264(6):549-62. PubMed ID: 19017179 [TBL] [Abstract][Full Text] [Related]
30. APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity. Yu G; Boone T; Delaney J; Hawkins N; Kelley M; Ramakrishnan M; McCabe S; Qiu WR; Kornuc M; Xia XZ; Guo J; Stolina M; Boyle WJ; Sarosi I; Hsu H; Senaldi G; Theill LE Nat Immunol; 2000 Sep; 1(3):252-6. PubMed ID: 10973284 [TBL] [Abstract][Full Text] [Related]
31. APRIL is overexpressed in cancer: link with tumor progression. Moreaux J; Veyrune JL; De Vos J; Klein B BMC Cancer; 2009 Mar; 9():83. PubMed ID: 19291294 [TBL] [Abstract][Full Text] [Related]
32. Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL. Chiu A; Xu W; He B; Dillon SR; Gross JA; Sievers E; Qiao X; Santini P; Hyjek E; Lee JW; Cesarman E; Chadburn A; Knowles DM; Cerutti A Blood; 2007 Jan; 109(2):729-39. PubMed ID: 16960154 [TBL] [Abstract][Full Text] [Related]
33. BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors. Zhang X; Park CS; Yoon SO; Li L; Hsu YM; Ambrose C; Choi YS Int Immunol; 2005 Jun; 17(6):779-88. PubMed ID: 15908449 [TBL] [Abstract][Full Text] [Related]
34. The role of the BAFF/APRIL system on T cell function. Mackay F; Leung H Semin Immunol; 2006 Oct; 18(5):284-9. PubMed ID: 16931039 [TBL] [Abstract][Full Text] [Related]
35. B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses. Xu S; Lam KP Mol Cell Biol; 2001 Jun; 21(12):4067-74. PubMed ID: 11359913 [TBL] [Abstract][Full Text] [Related]
36. Signals from activation of B-cell receptor with anti-IgD can override the stimulatory effects of excess BAFF on mature B cells in vivo. Nguyen TG; Morris JM Immunol Lett; 2014 Sep; 161(1):157-64. PubMed ID: 24954638 [TBL] [Abstract][Full Text] [Related]
37. The thymus is a source of B-cell-survival factors-APRIL and BAFF-in myasthenia gravis. Thangarajh M; Masterman T; Helgeland L; Rot U; Jonsson MV; Eide GE; Pirskanen R; Hillert J; Jonsson R J Neuroimmunol; 2006 Sep; 178(1-2):161-6. PubMed ID: 16820216 [TBL] [Abstract][Full Text] [Related]
38. Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease. Rickert RC; Jellusova J; Miletic AV Immunol Rev; 2011 Nov; 244(1):115-33. PubMed ID: 22017435 [TBL] [Abstract][Full Text] [Related]
39. TACI expression and signaling in chronic lymphocytic leukemia. Mamara A; Germenis AE; Kompoti M; Palassopoulou M; Mandala E; Banti A; Giannakoulas N; Speletas M J Immunol Res; 2015; 2015():478753. PubMed ID: 25950010 [TBL] [Abstract][Full Text] [Related]
40. Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF. Abu-Rish EY; Amrani Y; Browning MJ Rheumatology (Oxford); 2013 Jul; 52(7):1190-201. PubMed ID: 23436580 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]